Abstract
Histiocytic sarcoma is a type of lymphoma that rarely involves the central nervous system (CNS). Its rarity can easily lead to a misdiagnosis. We describe a patient with primary CNS histocytic sarcoma involving the cerebral hemisphere and spinal cord, who had been initially misdiagnosed as demyelinating disease. Two biopsies were necessary before a correct diagnosis was made. A histologic examination showed bizarre shaped histiocytes with larger nuclei and nuclear atypia. The cells were positive for CD68, CD163, and S-100 protein. As a resection was not feasible due to multifocality, he was treated with highdose methotrexate, but showed no response. As a result, he was switched to high dose cytarabine; but again, showed no response. The patient died 2 months from the start of chemotherapy and 8 months from the onset of symptoms. Since few patients with this condition have been described and histopathology is difficult to diagnose, suspicion of the disease is essential.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 322-328 |
| Number of pages | 7 |
| Journal | Cancer Research and Treatment |
| Volume | 47 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2015 |
Bibliographical note
Publisher Copyright:© 2015 by the Korean Cancer Association.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Central nervous system
- Cytarabine
- Histiocytic sarcoma
- Methotrexate
Fingerprint
Dive into the research topics of 'Primary histiocytic sarcoma of the central nervous system'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS